Abstract
The purpose of this study was to synthesize a novel prodrug of ethacrynic acid (ECA) with short chain polyethylene glycols (PEGs) and codrugs of ECA with the β-adrenergic blocking agent atenolol (ATL) or timolol (TML) to overcome the adverse effects of ECA and to enhance its physicochemical properties.
| Original language | English |
|---|---|
| Pages (from-to) | 3524-3527 |
| Number of pages | 4 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 15 |
| Issue number | 15 |
| DOIs | |
| State | Published - 1 Aug 2005 |
| Externally published | Yes |
Keywords
- Atenolol
- Codrug
- Ethacrynic acid
- Glaucoma
- Prodrug
- Timolol
Fingerprint
Dive into the research topics of 'Novel antiglaucoma prodrugs and codrugs of ethacrynic acid'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver